Imperial College London

DrPaulKemp

Faculty of MedicineNational Heart & Lung Institute

Reader in the Molecular Biology of Muscles
 
 
 
//

Contact

 

+44 (0)20 7594 1716p.kemp

 
 
//

Location

 

115Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Patel:2015:10.1002/jcsm.12096,
author = {Patel, MS and Lee, J and Baz, M and Wells, CE and Bloch, S and Lewis, A and Donaldson, AV and Garfield, B and Hopkinson, NS and Natanek, SA and Man, W and Wells, D and Baker, EH and Polkey, MI and Kemp, P},
doi = {10.1002/jcsm.12096},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
pages = {436--448},
title = {Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo},
url = {http://dx.doi.org/10.1002/jcsm.12096},
volume = {7},
year = {2015}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BackgroundLoss of muscle mass is a co-morbidity common to a range of chronic diseases including chronic obstructive pulmonary disease (COPD). Several systemic features of COPD including increased inflammatory signalling, oxidative stress, and hypoxia are known to increase the expression of growth differentiation factor-15 (GDF-15), a protein associated with muscle wasting in other diseases. We therefore hypothesized that GDF-15 may contribute to muscle wasting in COPD.MethodsWe determined the expression of GDF-15 in the serum and muscle of patients with COPD and analysed the association of GDF-15 expression with muscle mass and exercise performance. To determine whether GDF-15 had a direct effect on muscle, we also determined the effect of increased GDF-15 expression on the tibialis anterior of mice by electroporation.ResultsGrowth differentiation factor-15 was increased in the circulation and muscle of COPD patients compared with controls. Circulating GDF-15 was inversely correlated with rectus femoris cross-sectional area (P < 0.001) and exercise capacity (P < 0.001) in two separate cohorts of patients but was not associated with body mass index. GDF-15 levels were associated with 8-oxo-dG in the circulation of patients consistent with a role for oxidative stress in the production of this protein. Local over-expression of GDF-15 in mice caused wasting of the tibialis anterior muscle that expressed it but not in the contralateral muscle suggesting a direct effect of GDF-15 on muscle mass (P < 0.001).ConclusionsTogether, the data suggest that GDF-15 contributes to the loss of muscle mass in COPD.
AU - Patel,MS
AU - Lee,J
AU - Baz,M
AU - Wells,CE
AU - Bloch,S
AU - Lewis,A
AU - Donaldson,AV
AU - Garfield,B
AU - Hopkinson,NS
AU - Natanek,SA
AU - Man,W
AU - Wells,D
AU - Baker,EH
AU - Polkey,MI
AU - Kemp,P
DO - 10.1002/jcsm.12096
EP - 448
PY - 2015///
SN - 2190-6009
SP - 436
TI - Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo
T2 - Journal of Cachexia, Sarcopenia and Muscle
UR - http://dx.doi.org/10.1002/jcsm.12096
UR - http://hdl.handle.net/10044/1/29199
VL - 7
ER -